Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population

Donna Pauler Ankerst, Ryan Miyamoto, Prakash Vijay Nair, Brad H. Pollock, Ian M. Thompson, Dipen J Parekh

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: Prostate biopsy is often recommended based on increases in prostate specific antigen and/or abnormal digital rectal examination. We investigated the stability of a single positive test during the next 3 consecutive years. Materials and Methods: A total of 2,578 participants in a San Antonio screening cohort with 2 or more consecutive annual prostate specific antigen and digital rectal examination tests were identified. Occurrences of an increased prostate specific antigen (2.5 ng/ml or greater) followed by 1 or more nonincreased prostate specific antigen results were compared with similar fluctuations of digital rectal examination from abnormal to normal. Results: In 2,272 men who did not have a biopsy during the study, in 23.3% of 744 incidences of an increased prostate specific antigen with 1 year of followup, the next prostate specific antigen was not increased. In 19.5% of 462 incidences of an increased prostate specific antigen with 2 years of followup, the next 2 consecutive prostate specific antigen levels were not increased. Finally, in 17.5% of 285 incidences of an increased prostate specific antigen with 3 years of followup, the next 3 consecutive prostate specific antigens were not increased. Rates were similar but lower in 221 men with 1 or more negative biopsies during the study and in 85 men in whom prostate cancer eventually developed during the study. In contrast, approximately 70% of abnormal digital rectal examinations were normal the following year even in patients with prostate cancer, and in the majority of incidences remained normal the next 2 to 3 consecutive years. Conclusions: Occurrences of reversed prostate specific antigen cut point or abnormal digital rectal examination based decisions to biopsy 1 or more years after the initial test are not uncommon, suggesting repetition of these tests.

Original languageEnglish
Pages (from-to)2071-2076
Number of pages6
JournalJournal of Urology
Volume181
Issue number5
DOIs
StatePublished - May 1 2009
Externally publishedYes

Fingerprint

Digital Rectal Examination
Prostate-Specific Antigen
Population
Biopsy
Incidence
Prostatic Neoplasms
Prostate

Keywords

  • digital rectal examination
  • prostate-specific antigen
  • time factors

ASJC Scopus subject areas

  • Urology

Cite this

Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population. / Ankerst, Donna Pauler; Miyamoto, Ryan; Nair, Prakash Vijay; Pollock, Brad H.; Thompson, Ian M.; Parekh, Dipen J.

In: Journal of Urology, Vol. 181, No. 5, 01.05.2009, p. 2071-2076.

Research output: Contribution to journalArticle

Ankerst, Donna Pauler ; Miyamoto, Ryan ; Nair, Prakash Vijay ; Pollock, Brad H. ; Thompson, Ian M. ; Parekh, Dipen J. / Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population. In: Journal of Urology. 2009 ; Vol. 181, No. 5. pp. 2071-2076.
@article{add04a3abf9e44dbaaddfce0decb364d,
title = "Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population",
abstract = "Purpose: Prostate biopsy is often recommended based on increases in prostate specific antigen and/or abnormal digital rectal examination. We investigated the stability of a single positive test during the next 3 consecutive years. Materials and Methods: A total of 2,578 participants in a San Antonio screening cohort with 2 or more consecutive annual prostate specific antigen and digital rectal examination tests were identified. Occurrences of an increased prostate specific antigen (2.5 ng/ml or greater) followed by 1 or more nonincreased prostate specific antigen results were compared with similar fluctuations of digital rectal examination from abnormal to normal. Results: In 2,272 men who did not have a biopsy during the study, in 23.3{\%} of 744 incidences of an increased prostate specific antigen with 1 year of followup, the next prostate specific antigen was not increased. In 19.5{\%} of 462 incidences of an increased prostate specific antigen with 2 years of followup, the next 2 consecutive prostate specific antigen levels were not increased. Finally, in 17.5{\%} of 285 incidences of an increased prostate specific antigen with 3 years of followup, the next 3 consecutive prostate specific antigens were not increased. Rates were similar but lower in 221 men with 1 or more negative biopsies during the study and in 85 men in whom prostate cancer eventually developed during the study. In contrast, approximately 70{\%} of abnormal digital rectal examinations were normal the following year even in patients with prostate cancer, and in the majority of incidences remained normal the next 2 to 3 consecutive years. Conclusions: Occurrences of reversed prostate specific antigen cut point or abnormal digital rectal examination based decisions to biopsy 1 or more years after the initial test are not uncommon, suggesting repetition of these tests.",
keywords = "digital rectal examination, prostate-specific antigen, time factors",
author = "Ankerst, {Donna Pauler} and Ryan Miyamoto and Nair, {Prakash Vijay} and Pollock, {Brad H.} and Thompson, {Ian M.} and Parekh, {Dipen J}",
year = "2009",
month = "5",
day = "1",
doi = "10.1016/j.juro.2009.01.029",
language = "English",
volume = "181",
pages = "2071--2076",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population

AU - Ankerst, Donna Pauler

AU - Miyamoto, Ryan

AU - Nair, Prakash Vijay

AU - Pollock, Brad H.

AU - Thompson, Ian M.

AU - Parekh, Dipen J

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Purpose: Prostate biopsy is often recommended based on increases in prostate specific antigen and/or abnormal digital rectal examination. We investigated the stability of a single positive test during the next 3 consecutive years. Materials and Methods: A total of 2,578 participants in a San Antonio screening cohort with 2 or more consecutive annual prostate specific antigen and digital rectal examination tests were identified. Occurrences of an increased prostate specific antigen (2.5 ng/ml or greater) followed by 1 or more nonincreased prostate specific antigen results were compared with similar fluctuations of digital rectal examination from abnormal to normal. Results: In 2,272 men who did not have a biopsy during the study, in 23.3% of 744 incidences of an increased prostate specific antigen with 1 year of followup, the next prostate specific antigen was not increased. In 19.5% of 462 incidences of an increased prostate specific antigen with 2 years of followup, the next 2 consecutive prostate specific antigen levels were not increased. Finally, in 17.5% of 285 incidences of an increased prostate specific antigen with 3 years of followup, the next 3 consecutive prostate specific antigens were not increased. Rates were similar but lower in 221 men with 1 or more negative biopsies during the study and in 85 men in whom prostate cancer eventually developed during the study. In contrast, approximately 70% of abnormal digital rectal examinations were normal the following year even in patients with prostate cancer, and in the majority of incidences remained normal the next 2 to 3 consecutive years. Conclusions: Occurrences of reversed prostate specific antigen cut point or abnormal digital rectal examination based decisions to biopsy 1 or more years after the initial test are not uncommon, suggesting repetition of these tests.

AB - Purpose: Prostate biopsy is often recommended based on increases in prostate specific antigen and/or abnormal digital rectal examination. We investigated the stability of a single positive test during the next 3 consecutive years. Materials and Methods: A total of 2,578 participants in a San Antonio screening cohort with 2 or more consecutive annual prostate specific antigen and digital rectal examination tests were identified. Occurrences of an increased prostate specific antigen (2.5 ng/ml or greater) followed by 1 or more nonincreased prostate specific antigen results were compared with similar fluctuations of digital rectal examination from abnormal to normal. Results: In 2,272 men who did not have a biopsy during the study, in 23.3% of 744 incidences of an increased prostate specific antigen with 1 year of followup, the next prostate specific antigen was not increased. In 19.5% of 462 incidences of an increased prostate specific antigen with 2 years of followup, the next 2 consecutive prostate specific antigen levels were not increased. Finally, in 17.5% of 285 incidences of an increased prostate specific antigen with 3 years of followup, the next 3 consecutive prostate specific antigens were not increased. Rates were similar but lower in 221 men with 1 or more negative biopsies during the study and in 85 men in whom prostate cancer eventually developed during the study. In contrast, approximately 70% of abnormal digital rectal examinations were normal the following year even in patients with prostate cancer, and in the majority of incidences remained normal the next 2 to 3 consecutive years. Conclusions: Occurrences of reversed prostate specific antigen cut point or abnormal digital rectal examination based decisions to biopsy 1 or more years after the initial test are not uncommon, suggesting repetition of these tests.

KW - digital rectal examination

KW - prostate-specific antigen

KW - time factors

UR - http://www.scopus.com/inward/record.url?scp=64049086210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049086210&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.01.029

DO - 10.1016/j.juro.2009.01.029

M3 - Article

C2 - 19286205

AN - SCOPUS:64049086210

VL - 181

SP - 2071

EP - 2076

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -